Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2007-05-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM070219PPMID 17530838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.

  2006cited by this paper
• Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells.

  2005cited by this paper
• Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

  2005cited by this paper
• Stearoyl‐CoA desaturase as a new drug target for obesity treatment

  2005cited by this paper
• Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.

  2005cited by this paper
• Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates.

  2005cited by this paper
• NADH Cytochrome b5 Reductase and Cytochrome b5 Catalyze the Microsomal Reduction of Xenobiotic Hydroxylamines and Amidoximes in Humans

  2004cited by this paper
• Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400039-JLR200

  2004cited by this paper
• The role of stearoyl-CoA desaturase in body weight regulation.

  2004cited by this paper
• Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells

  2004cited by this paper
• An improved method for tissue long-chain acyl-CoA extraction and analysis Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.D400004-JLR200

  2004cited by this paper
• Lipid overload and overflow: metabolic trauma and the metabolic syndrome.

  2003cited by this paper
• Recent insights into stearoyl-CoA desaturase-1

  2003cited by this paper
• Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle

  2003cited by this paper
• Identification and Characterization of Murine SCD4, a Novel Heart-specific Stearoyl-CoA Desaturase Isoform Regulated by Leptin and Dietary Factors*

  2003cited by this paper
• Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

  2002cited by this paper
• Lack of stearoyl-CoA desaturase-1 function induces a palmitoyl-CoA Delta6 desaturase and represses the stearoyl-CoA desaturase-3 gene in the preputial glands of the mouse.

  2002cited by this paper
• Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200189-JLR200

  2002cited by this paper
• Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity

  2002cited by this paper
• Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites.

  1999cited by this paper
• The regulation of stearoyl-CoA desaturase (SCD).

  1995cited by this paper
• Analysis of long-chain fatty acyl coenzyme a thioesters by negative ion fast-atom bombardment mass spectrometry and tandem mass spectrometry

  1994cited by this paper
• Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor.

  1991cited by this paper
• Synthesis and antihypertensive activity of new 6-heteroaryl-3-hydrazinopyridazine derivatives.

  1981cited by this paper
• Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid.

  1976cited by this paper

• Metabolic crosstalk in the metastatic prostate cancer-bone microenvironment: mechanism, detection and therapeutic strategies.

  2026cites this paper
• LPS2336, a New TREK-1 Channel Activator Identified by High Throughput Screening

  2025cites this paper
• Inhibition of SCD1 attenuates neuroinflammation and brain injury after cerebral ischemia-reperfusion.

  2025cites this paper
• An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors

  2024cites this paper
• A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response

  2024cites this paper
• Cis-vaccenic acid is a key product of stearoyl-CoA desaturase 1 and a critical oncogenic factor in prostate cancer

  2024cites this paper
• A fast-acting lipid checkpoint in G1 prevents mitotic defects

  2024cites this paper
• Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer

  2023cites this paper
• Desaturation of sebaceous‐type saturated fatty acids through the SCD1 and the FADS2 pathways impacts lipid neosynthesis and inflammatory response in sebocytes in culture

  2023cites this paper
• Plasticizer acetyl triethyl citrate (ATEC) induces lipogenesis and obesity.

  2023cites this paper
• Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy.

  2022cites this paper
• Progress of potential drugs targeted in lipid metabolism research

  2022cites this paper
• Single cell mass spectrometry studies reveal metabolomic features and potential mechanisms of drug-resistant cancer cell lines.

  2022cites this paper
• Isobaric 6-plex and tosyl dual tagging for the determination of positional isomers and quantitation of monounsaturated fatty acids using rapid UHPLC-MS/MS.

  2022cites this paper
• Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease

  2022cites this paper
• Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation

  2021influential citation
• Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity.

  2021cites this paper
• Lipid metabolism in cancer: New perspectives and emerging mechanisms.

  2021cites this paper
• Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.

  2021cites this paper
• SCD Inhibition Protects from α-Synuclein-Induced Neurotoxicity But Is Toxic to Early Neuron Cultures

  2021influential citation
• Structure-based virtual screening of natural products as potential stearoyl-coenzyme a desaturase 1 (SCD1) inhibitors

  2020cites this paper
• BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1/HMGCR module.

  2020cites this paper
• Large-scale lipid analysis with C=C location and sn-position isomer resolving power

  2020cites this paper
• Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases

  2020cites this paper
• Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase.

  2020cites this paper
• Synthesis and biological evaluation of 3-amino-, 3-alkoxy- and 3-aryloxy-6-(hetero)arylpyridazines as potent antitumor agents.

  2019cites this paper
• Human colon organoids reveal distinct physiologic and oncogenic Wnt responses

  2019cites this paper
• Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication.

  2019cites this paper
• Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation

  2019cites this paper
• A hydroxylamine probe for profiling S-acylated fatty acids on proteins.

  2019cites this paper
• Real time quantitative analysis of lipid storage and lipolysis pathways by confocal spectral imaging of intracellular micropolarity.

  2018cites this paper
• Responses of MAC-T Cells to Inhibited Stearoyl-CoA Desaturase 1 during cis-9, trans-11 Conjugated Linoleic Acid Synthesis.

  2018cites this paper
• miR-127 aggravates myocardial failure by promoting the TGF-β1/Smad3 signaling

  2018cites this paper
• Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase.

  2018cites this paper
• Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity.

  2018cites this paper
• Analytical Studies on the Impact of Smoking Cessation on the Metabolic Profile

  2018cites this paper
• Fatty acid metabolism and prospects for targeted therapy of cancer

  2017cites this paper
• Mitochondrial adaptation in steatotic mice.

  2017cites this paper
• Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.

  2017cites this paper
• In vitro and in vivo antitumor activities of T‐3764518, a novel and orally available small molecule stearoyl‐CoA desaturase 1 inhibitor

  2017cites this paper
• Mitochondrial adaptations to dietary lipids in liver steatosis prevent hepatotoxicity but sensitize to secondary liver insult

  2017cites this paper
• Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

  2017cites this paper
• Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

  2017cites this paper
• Lipid Desaturation Is a Me tabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells Graphical

  2017cites this paper
• Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.

  2017cites this paper
• Tetrahydrobenzothiophene carboxamides: Beyond the kinase domain and into the fatty acid realm.

  2017cites this paper
• Discovery of Tumor-Specific Irreversible Inhibitors of Stearoyl CoA Desaturase

  2016cites this paper
• Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors.

  2016cites this paper
• Coincident Phosphatidic Acid Interaction Restrains Drp1 in Mitochondrial Division.

  2016cites this paper
• INHIBITION OF FATTY ACID DESATURASES IN Drosophila melanogaster LARVAE BLOCKS FEEDING AND DEVELOPMENTAL PROGRESSION.

  2016cites this paper
• Chemical Probes to Directly Profile Palmitoleoylation of Proteins

  2016cites this paper
• Squaramides with cytotoxic activity against human gastric carcinoma cells HGC-27: synthesis and mechanism of action

  2016cites this paper
• Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytes

  2015cites this paper
• Roles of unsaturated fatty acids in autophagy

  2015cites this paper
• Proteomic Analysis Reveals PGAM1 Altering cis-9, trans-11 Conjugated Linoleic Acid Synthesis in Bovine Mammary Gland

  2015cites this paper
• SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway.

  2015cites this paper
• Role of p38 mitogen‐activated protein kinase in linking stearoyl‐CoA desaturase‐1 activity with endoplasmic reticulum homeostasis

  2015cites this paper
• Selective mono-amination of dichlorodiazines

  2015cites this paper
• Metal Catalyzed Cross-Coupling Reactions in the Decoration of Pyrimidine, Pyridazine, and Pyrazine

  2014cites this paper
• Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.

  2014cites this paper
• Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.

  2014cites this paper
• Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease.

  2014cites this paper
• Stearoyl Coenzyme A Desaturase 1 Is Associated with Hepatitis C Virus Replication Complex and Regulates Viral Replication

  2014cites this paper
• Metabolomics investigations in body fluids of smokers and non-smokers

  2014cites this paper
• Stearoyl-CoA Desaturase 1 Activity Is Required for Autophagosome Formation*

  2014cites this paper
• Organocatalytic one-pot synthesis of highly substituted pyridazines from Morita-Baylis-Hillman carbonates and diazo compounds.

  2014cites this paper
• 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs.

  2013cites this paper
• Role of stearoyl-CoA desaturase-1 in maintaining muscle activity : study of a lesion model for understanding the meatbolic alterations characteristics of amyotrophic lateral sclerosis

  2013cites this paper
• The fat side of prostate cancer.

  2013cites this paper
• An electrochemical nickel-catalyzed arylation of 3-amino-6-chloropyridazines.

  2013cites this paper
• Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter.

  2013cites this paper
• Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.

  2013cites this paper
• Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).

  2013cites this paper
• 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.

  2013cites this paper
• Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.

  2013cites this paper
• SCD 1 Inhibition Causes Cancer Cell Death by Depleting MonoUnsaturated Fatty Acids

  2012influential citation
• SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids

  2012influential citation
• Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.

  2012cites this paper
• Palmitoleate Is a Mitogen, Formed upon Stimulation with Growth Factors, and Converted to Palmitoleoyl-phosphatidylinositol*

  2012cites this paper
• Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.

  2012cites this paper
• Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis

  2011cites this paper
• Lipogenic enzymes as therapeutic targets for obesity and diabetes.

  2011cites this paper
• Signaling and Regulation Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy

  2011cites this paper
• Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors.

  2011cites this paper
• Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.

  2011cites this paper
• N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors.

  2011cites this paper
• Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy.

  2011cites this paper
• Rank Order Entropy: Why One Metric Is Not Enough

  2011cites this paper
• High-Throughput Scintillation Proximity Assay for Stearoyl-CoA Desaturase-1

  2011cites this paper
• Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy

  2011cites this paper
• Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis

  2011cites this paper
• Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).

  2010cites this paper
• Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.

  2010cites this paper
• Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6.

  2010cites this paper
• Recent advances in stearoyl-CoA desaturase 1 inhibitors for dyslipidemia and obesity.

  2010cites this paper
• When analoging is not enough: scaffold discovery in medicinal chemistry

  2010cites this paper
• Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase

  2010cites this paper
• Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men.

  2010cites this paper
• Unsaturated Fatty Acids

  2010cites this paper
• Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats.

  2010cites this paper